Pangaea Biosciences Ltd

POWER SEARCH PRICING

SOLUTIONS

pangaea biosciences ltd Company Information

Company Number

08274925

Next Accounts

Jul 2025

Directors

Nicholas Gooch

Shareholders

nicholas anthony gooch

michael gifford

Group Structure

View All

Industry

Research and experimental development on biotechnology

Registered Address

st john's innovation centre, cowley road, cambridge, CB4 0WS

Website

www.pangaeaagrochemicals.co.uk

pangaea biosciences ltd Estimated Valuation

£26.8m

Pomanda estimates the enterprise value of PANGAEA BIOSCIENCES LTD at £26.8m based on Net Assets of £14.6m and 1.84x industry multiple (adjusted for liquidity).

Edit your figures and get a professional valuation report.

Pangaea Biosciences Ltd is a live company located in cambridge, CB4 0WS with a Companies House number of 08274925. It operates in the research and experimental development on biotechnology sector, SIC Code 72110. Founded in October 2012, it's largest shareholder is nicholas anthony gooch with a 95% stake. Pangaea Biosciences Ltd is a established, small sized company, Pomanda has estimated its turnover at £2.1m with high growth in recent years.

View Sample

Upgrade for unlimited company reports & a free credit check

Pomanda's financial health check has awarded Pangaea Biosciences Ltd a 3.5 rating. We use a traffic light system to show it exceeds the industry average on 4 measures and has 5 areas for improvement. Company Health Check FAQs

Health Rating3.5out of 5

4 Strong

1 Regular

5 Weak

Size

annual sales of £2.1m, make it smaller than the average company (£3.3m)

Growth

3 year (CAGR) sales growth of 27%, show it is growing at a faster rate (12.5%)

EXPORT

Pangaea Biosciences Ltd's latest turnover from October 2023 is estimated at £2.1 million and the company has net assets of £14.6 million. According to their latest financial statements, Pangaea Biosciences Ltd has 8 employees and maintains cash reserves of 0 as reported in the balance sheet.

Data source: Companies House, Pomanda Estimates

	Oct 2023	Oct 2022	Oct 2021	Oct 2020	Oct 2019	Oct 2018	Oct 2017	Oct 2016	Oct 2015	Oct 2014	Oct 2013
Turnover	2,088,263	1,943,804	1,103,411	1,012,106	1,393,320	508,192	501,695	280,655	353,045	369,821	104,993
Other Income Or Grants	0	0	0	0	0	0	0	0	0	0	0
Cost Of Sales	1,556,520	1,346,022	822,888	654,653	939,141	348,613	342,298	192,547	243,602	258,689	77,999
Gross Profit	531,743	597,783	280,523	357,454	454,180	159,579	159,398	88,108	109,443	111,132	26,994
Admin Expenses	1,448,751	1,656,308	-6,528,447	-15,306,913	793,883	724,038	270,249	218,841	293,754	322,164	117,590
Operating Profit	-917,008	-1,058,525	6,808,970	15,664,367	-339,703	-564,459	-110,851	-130,733	-184,311	-211,032	-90,596
Interest Payable	0	0	0	0	0	0	0	0	0	0	0
Interest Receivable	0	0	0	15	114	0	0	0	0	0	0
Pre-Tax Profit	-917,008	-1,058,525	6,808,970	15,664,383	-339,589	-564,459	-110,851	-130,733	-184,311	-211,032	-90,596
Tax	0	0	-1,293,704	-2,976,233	0	0	0	0	0	0	0
Profit After Tax	-917,008	-1,058,525	5,515,266	12,688,150	-339,589	-564,459	-110,851	-130,733	-184,311	-211,032	-90,596
Dividends Paid	0	0	0	0	0	0	0	0	0	0	0
Retained Profit	-917,008	-1,058,525	5,515,266	12,688,150	-339,589	-564,459	-110,851	-130,733	-184,311	-211,032	-90,596
Employee Costs	610,709	586,548	500,784	749,529	663,948	129,358	164,945	115,067	109,550	161,016	51,055
Number Of Employees	8	8	7	11	10	2	3	2	2	3	1
EBITDA*	-917,008	-1,058,525	6,808,970	15,665,122	-339,703	-564,459	-110,851	-126,733	-180,311	-207,032	-86,596

* Earnings Before Interest, Tax, Depreciation and Amortisation

	Oct 2023	Oct 2022	Oct 2021	Oct 2020	Oct 2019	Oct 2018	Oct 2017	Oct 2016	Oct 2015	Oct 2014	Oct 2013
Tangible Assets	20,248,913	20,203,762	20,203,898	1,049	1,804	37,643	40,000	0	0	0	0
Intangible Assets	0	0	0	13,125,000	35,404	0	0	44,000	48,000	52,000	56,000
Investments & Other	0	0	0	0	0	0	0	0	0	0	0
Debtors (Due After 1 year)	0	0	0	0	0	0	0	0	0	0	0
Total Fixed Assets	20,248,913	20,203,762	20,203,898	13,126,049	37,208	37,643	40,000	44,000	48,000	52,000	56,000
Stock & work in progress	0	0	0	0	0	0	0	0	0	0	0
Trade Debtors	735,252	498,634	242,074	222,456	474,504	19,114	95,510	44,725	72,963	0	0
Group Debtors	0	0	0	0	0	0	0	0	0	0	0
Misc Debtors	0	0	0	0	0	0	0	0	0	0	0
Cash	0	0	0	269	30,361	0	0	160	170	0	0
misc current assets	0	0	0	1,049	0	0	0	0	0	0	0
total current assets	735,252	498,634	242,074	223,774	504,865	19,114	95,510	44,885	73,133	0	0
total assets	20,984,165	20,702,396	20,445,972	13,349,823	542,073	56,757	135,510	88,885	121,133	52,000	56,000
Bank overdraft	0	0	0	0	0	0	0	0	0	0	0
Bank loan	0	0	0	0	0	0	0	0	0	0	0
Trade Creditors	6,387,853	5,189,076	3,874,127	2,090,950	1,975,350	1,348,739	863,033	558,577	606,092	353,528	146,496
Group/Directors Accounts	0	0	0	0	0	0	0	0	0	0	0
other short term finances	0	0	0	0	0	0	0	0	0	0	0
hp & lease commitments	0	0	0	0	0	0	0	0	0	0	0
other current liabilities	0	0	0	0	0	0	0	0	0	0	0
total current liabilities	6,387,853	5,189,076	3,874,127	2,090,950	1,975,350	1,348,739	863,033	558,577	606,092	353,528	146,496
loans	0	0	0	0	0	0	0	0	0	0	0
hp & lease commitments	0	0	0	0	0	0	0	0	0	0	0
Accruals and Deferred Income	0	0	0	55,314	51,314	0	0	0	0	0	0
other liabilities	0	0	0	0	0	0	0	0	0	0	0
provisions	0	0	0	0	0	0	0	0	0	0	0
total long term liabilities	0	0	0	55,314	51,314	0	0	0	0	0	0
total liabilities	6,387,853	5,189,076	3,874,127	2,146,264	2,026,664	1,348,739	863,033	558,577	606,092	353,528	146,496
net assets	14,596,312	15,513,320	16,571,845	11,203,559	-1,484,591	-1,291,982	-727,523	-469,692	-484,959	-301,528	-90,496
total shareholders funds	14,596,312	15,513,320	16,571,845	11,203,559	-1,484,591	-1,291,982	-727,523	-469,692	-484,959	-301,528	-90,496

	Oct 2023	Oct 2022	Oct 2021	Oct 2020	Oct 2019	Oct 2018	Oct 2017	Oct 2016	Oct 2015	Oct 2014	Oct 2013
Operating Activities
Operating Profit	-917,008	-1,058,525	6,808,970	15,664,367	-339,703	-564,459	-110,851	-130,733	-184,311	-211,032	-90,596
Depreciation	0	0	0	755	0	0	0	0	0	0	0
Amortisation	0	0	0	0	0	0	0	4,000	4,000	4,000	4,000
Tax	0	0	-1,293,704	-2,976,233	0	0	0	0	0	0	0
Stock	0	0	0	0	0	0	0	0	0	0	0
Debtors	236,618	256,560	19,618	-252,048	455,390	-76,396	50,785	-28,238	72,963	0	0
Creditors	1,198,777	1,314,949	1,783,177	115,600	626,611	485,706	304,456	-47,515	252,564	207,032	146,496
Accruals and Deferred Income	0	0	-55,314	4,000	51,314	0	0	0	0	0	0
Deferred Taxes & Provisions	0	0	0	0	0	0	0	0	0	0	0
Cash flow from operations	45,151	-136	7,223,511	13,060,537	-117,168	-2,357	142,820	-146,010	-710	0	59,900
Investing Activities
capital expenditure	-45,151	136	-7,077,849	-13,089,596	435	2,357	4,000	0	0	0	-60,000
Change in Investments	0	0	0	0	0	0	0	0	0	0	0
cash flow from investments	-45,151	136	-7,077,849	-13,089,596	435	2,357	4,000	0	0	0	-60,000
Financing Activities
Bank loans	0	0	0	0	0	0	0	0	0	0	0
Group/Directors Accounts	0	0	0	0	0	0	0	0	0	0	0
Other Short Term Loans	0	0	0	0	0	0	0	0	0	0	0
Long term loans	0	0	0	0	0	0	0	0	0	0	0
Hire Purchase and Lease Commitments	0	0	0	0	0	0	0	0	0	0	0
other long term liabilities	0	0	0	0	0	0	0	0	0	0	0
share issue	0	0	-146,980	0	146,980	0	-146,980	146,000	880	0	100
interest	0	0	0	15	114	0	0	0	0	0	0
cash flow from financing	0	0	-146,980	15	147,094	0	-146,980	146,000	880	0	100
cash and cash equivalents
cash	0	0	-269	-30,092	30,361	0	-160	-10	170	0	0
overdraft	0	0	0	0	0	0	0	0	0	0	0
change in cash	0	0	-269	-30,092	30,361	0	-160	-10	170	0	0

Very Low Risk70 - 100

Low Risk50 - 70

Moderate Risk30 - 50

High Risk20 - 30

Very High Risk0 - 20

Get a comprehensive credit check for pangaea biosciences ltd. Get real-time insights into pangaea biosciences ltd's credit score, group structure and payment trends.

From as little as £6.99

This will not impact your credit rating!

View Credit Report Sample

Perform a competitor analysis for pangaea biosciences ltd by selecting its closest rivals, whether from the PROFESSIONAL, SCIENTIFIC AND TECHNICAL ACTIVITIES sector, other small companies, companies in CB4 area or any other competitors across 12 key performance metrics.

PANGAEA BIOSCIENCES LTD group structure

Pangaea Biosciences Ltd has no subsidiary companies.

Ultimate parent company

PANGAEA BIOSCIENCES LTD

08274925

PANGAEA BIOSCIENCES LTD Shareholders

nicholas anthony gooch	95%
michael gifford	5%

Pangaea Biosciences Ltd currently has 1 director, Mr Nicholas Gooch serving since Oct 2012.

officer	country	age	start	end	role
Mr Nicholas Gooch	United Kingdom	65 years	Oct 2012	-	Director

P&L

October 2023

turnover

2.1m

+7%

operating profit

-917k

gross margin

25.5%

-17.2%

turnover

Turnover, or revenue, is the amount of sales generated by a company within the financial year.

Balance Sheet

October 2023

net assets

14.6m

-0.06%

total assets

21m

+0.01%

cash

net assets

Total assets minus all liabilities

Similar Companies

macrophage pharma limited

4.5

company number

08274925

Type

Private limited with Share Capital

industry

72110 - Research and experimental development on biotechnology

incorporation date

October 2012

ultimate parent company

None

previous names

pangaea agrochemicals limited (November 2022)

address

st john's innovation centre, cowley road, cambridge, CB4 0WS

A charge, or mortgage, refers to the rights a company gives to a lender in return for a loan, often in the form of security given over business assets.

We found 4 charges/mortgages relating to pangaea biosciences ltd. Currently there are 3 open charges and 1 have been satisfied in the past.

When a company issues new shares, e.g. to new investors following a funding round, it is required to notify Companies House within one month of making an allotment of shares.

Click to start generating capital raising & share issue transactions for PANGAEA BIOSCIENCES LTD. This can take several minutes, an email will notify you when this has completed.

pangaea biosciences ltd Company Information

pangaea biosciences ltd Estimated Valuation

pangaea biosciences ltd Estimated Valuation

pangaea biosciences ltd Estimated Valuation

Pangaea Biosciences Ltd Overview

Pangaea Biosciences Ltd Health Check

PANGAEA BIOSCIENCES LTD financials

pangaea biosciences ltd Credit Report and Business Information

Pangaea Biosciences Ltd Competitor Analysis

pangaea biosciences ltd Ownership

pangaea biosciences ltd directors

pangaea biosciences ltd company details

pangaea biosciences ltd Charges & Mortgages

pangaea biosciences ltd Capital Raised & Share Issues BETA

pangaea biosciences ltd Companies House Filings - See Documents